Procalcitonin kinetics after burn injury and burn surgery in septic and non-septic patients – a retrospective observational study

[1]  M. Ciccozzi,et al.  The role of procalcitonin in the diagnosis of bacterial infection after major abdominal surgery , 2018, Medicine.

[2]  G. Lippi,et al.  Academy of Emergency Medicine and Care-Society of Clinical Biochemistry and Clinical Molecular Biology consensus recommendations for clinical use of sepsis biomarkers in the emergency department , 2017 .

[3]  V. Afreixo,et al.  Procalcitonin for the early diagnosis of sepsis in burn patients: A retrospective study. , 2017, Burns : journal of the International Society for Burn Injuries.

[4]  Michel Wolff,et al.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2017, The Cochrane database of systematic reviews.

[5]  D. Herndon,et al.  Predicting and managing sepsis in burn patients: current perspectives , 2017, Therapeutics and clinical risk management.

[6]  D. Greenhalgh.  Sepsis in the burn patient: a different problem than sepsis in the general population , 2017, Burns & Trauma.

[7]  A. Pernestig,et al.  Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis , 2017, PloS one.

[8]  György J. Simon,et al.  Does serum procalcitonin aid in the diagnosis of bloodstream infection regardless of whether patients exhibit the systemic inflammatory response syndrome? , 2017, Infection.

[9]  I. Ciuca,et al.  Early Prediction of Sepsis Incidence in Critically Ill Patients Using Specific Genetic Polymorphisms , 2016, Biochemical Genetics.

[10]  Z. Molnár,et al.  Procalcitonin – Assisted Antibiotic Strategy in Sepsis , 2017, EJIFCC.

[11]  W. Self,et al.  Serial Procalcitonin Predicts Mortality in Severe Sepsis Patients: Results From the Multicenter Procalcitonin MOnitoring SEpsis (MOSES) Study , 2017, Critical care medicine.

[12]  B. Long,et al.  Ready for Prime Time? Biomarkers in Sepsis. , 2017, Emergency medicine clinics of North America.

[13]  P. Schuetz,et al.  Procalcitonin-guided diagnosis and antibiotic stewardship revisited , 2017, BMC Medicine.

[14]  V. Afreixo,et al.  The Use of Procalcitonin (PCT) for Diagnosis of Sepsis in Burn Patients: A Meta-Analysis , 2016, PloS one.

[15]  J. Lord,et al.  The diagnostic and prognostic value of systems biology research in major traumatic and thermal injury: a review , 2016, Burns & Trauma.

[16]  L. Steuten,et al.  Economic value of procalcitonin guidance. , 2016, Lancet. Infectious Diseases (Print).

[17]  F. Bert,et al.  Serum Procalcitonin as a Valuable Diagnostic Tool in the Early Detection of Infectious Complications after Open Abdominal Aortic Repair. , 2016, Annals of vascular surgery.

[18]  Tom Dormans,et al.  Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. , 2016, The Lancet. Infectious diseases.

[19]  E. Miranda,et al.  C-Reactive Protein and Procalcitonin as Early Markers of Septic Complications after Laparoscopic Sleeve Gastrectomy in Morbidly Obese Patients Within an Enhanced Recovery After Surgery Program. , 2016, Journal of the American College of Surgeons.

[20]  J. Vincent,et al.  The Clinical Challenge of Sepsis Identification and Monitoring , 2016, PLoS medicine.

[21]  D. Herndon,et al.  Infection in Burns. , 2016, Surgical infections.

[22]  J. Barret,et al.  Recent Advances in Biomarkers in Severe Burns , 2016, Shock.

[23]  G. Durek,et al.  Procalcitonin kinetics – prognostic and diagnostic significance in septic patients , 2016, Archives of medical science : AMS.

[24]  P. Honore,et al.  The struggle to differentiate inflammation from infection in severely burned patients: time to send better biomarkers into the arena? , 2015, Critical Care.

[25]  A. Rodríguez-Rodríguez,et al.  The utility of C-reactive protein and procalcitonin for sepsis diagnosis in critically burned patients: A preliminary study , 2015 .

[26]  Jeong Hoon Yang,et al.  Clinical Usefulness of Procalcitonin and C-Reactive Protein as Outcome Predictors in Critically Ill Patients with Severe Sepsis and Septic Shock , 2015, PloS one.

[27]  H. Oueslati,et al.  Procalcitonin: a diagnostic and prognostic biomarker of sepsis in burned patients. , 2015, Annals of burns and fire disasters.

[28]  L. Su,et al.  Prognostic Value of Procalcitonin in Adult Patients with Sepsis: A Systematic Review and Meta-Analysis , 2015, PloS one.

[29]  D. Nieboer,et al.  The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis , 2015 .

[30]  Chunmao Han,et al.  Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: a meta-analysis. , 2015, Burns : journal of the International Society for Burn Injuries.

[31]  J. Schreinemakers,et al.  Searching for predictors of surgical complications in critically ill surgery patients in the intensive care unit: a review , 2015, Surgery Today.

[32]  Alexander A. Morgan,et al.  Prediction of multiple infections after severe burn trauma: a prospective cohort study. , 2015, Annals of surgery.

[33]  J. Vincent,et al.  Sepsis biomarkers. Value and limitations. , 2014, American journal of respiratory and critical care medicine.

[34]  P. Marik,et al.  Don’t miss the diagnosis of sepsis! , 2014, Critical Care.

[35]  H. Wong,et al.  Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment , 2014, Expert review of clinical immunology.

[36]  Xia Fan,et al.  Prediction of sepsis in trauma patients , 2014, Burns & Trauma.

[37]  M. Meisner.  Update on Procalcitonin Measurements , 2014, Annals of laboratory medicine.

[38]  J. Garnacho-Montero,et al.  Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis , 2014, Critical Care.

[39]  R. Galeiras,et al.  Procalcitonin in the burn unit and the diagnosis of infection. , 2014, Burns : journal of the International Society for Burn Injuries.

[40]  P. Giannoudis,et al.  Biomarkers predicting sepsis in polytrauma patients: Current evidence. , 2013, Injury.

[41]  S. Mubareka,et al.  Identification of predictors of early infection in acute burn patients. , 2013, Burns : journal of the International Society for Burn Injuries.

[42]  H. Friess,et al.  Procalcitonin ratio as a predictor of successful surgical treatment of severe necrotizing soft tissue infections. , 2013, American journal of surgery.

[43]  Peter Schlattmann,et al.  Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.

[44]  W. Chun,et al.  Procalcitonin levels within 48 hours after burn injury as a prognostic factor. , 2012, Annals of clinical and laboratory science.

[45]  Stefan Riedel,et al.  Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis. , 2012, Diagnostic microbiology and infectious disease.

[46]  A. Lavrentieva,et al.  PCT as a diagnostic and prognostic tool in burn patients. Whether time course has a role in monitoring sepsis treatment. , 2012, Burns : journal of the International Society for Burn Injuries.

[47]  É. Azoulay,et al.  Diagnostic accuracy of procalcitonin in critically ill immunocompromised patients , 2011, BMC infectious diseases.

[48]  Jeffrey L. Greenwald,et al.  Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. , 2011, Archives of internal medicine.

[49]  C. Wade,et al.  Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. , 2011, Burns : journal of the International Society for Burn Injuries.

[50]  G. Barlow,et al.  Diagnostic and prognostic biomarkers of sepsis in critical care. , 2011, The Journal of antimicrobial chemotherapy.

[51]  M. Christ-Crain,et al.  Procalcitonin for guidance of antibiotic therapy , 2010, Expert review of anti-infective therapy.

[52]  J. Vincent,et al.  Sepsis biomarkers: a review , 2010, Critical care.

[53]  F. Tubach,et al.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial , 2010, The Lancet.

[54]  J. Quenot,et al.  Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report , 2009, BMC infectious diseases.

[55]  Markus Schwehm,et al.  Antiviral prophylaxis during pandemic influenza may increase drug resistance , 2009, BMC infectious diseases.

[56]  B. Seifert,et al.  Early Serum Procalcitonin, Interleukin-6, and 24-Hour Lactate Clearance: Useful Indicators of Septic Infections in Severely Traumatized Patients , 2009, World Journal of Surgery.

[57]  Hamid Karimi,et al.  Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases. , 2008, Burns : journal of the International Society for Burn Injuries.

[58]  R. Gamelli,et al.  American Burn Association Consensus Conference to Define Sepsis and Infection in Burns , 2007, Journal of burn care & research : official publication of the American Burn Association.

[59]  J. Catineau,et al.  Evaluation of serum procalcitonin concentration in the ICU following severe burn. , 2007, Burns : journal of the International Society for Burn Injuries.

[60]  C. Murray.  Infections in burns. , 2007, The Journal of trauma.

[61]  Anthony S McLean,et al.  Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.

[62]  A. Lavrentieva,et al.  Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis? , 2007, Burns : journal of the International Society for Burn Injuries.

[63]  K. Reinhart,et al.  Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature , 2006, Critical care.

[64]  P. Rehak,et al.  Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. , 2006, British journal of anaesthesia.

[65]  Z. Molnár,et al.  Let's go dynamic with procalcitonin! , 2006, Critical care medicine.

[66]  J. Blache,et al.  Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. , 2005, British journal of anaesthesia.

[67]  D. Pittet,et al.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. , 2001, American journal of respiratory and critical care medicine.

[68]  H. Machens,et al.  Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury. , 1999, The Journal of burn care & rehabilitation.

[69]  N. Pallua,et al.  Procalcitonin--a sepsis parameter in severe burn injuries. , 1998, Burns : journal of the International Society for Burn Injuries.

[70]  J. Schüttler,et al.  Postoperative plasma concentrations of procalcitonin after different types of surgery , 1998, Intensive Care Medicine.

[71]  Sameer S. Kadri,et al.  Effect of Procalcitonin Testing on Health‐care Utilization and Costs in Critically Ill Patients in the United States , 2017, Chest.

[72]  J. Vincent,et al.  Host response biomarkers in sepsis: the role of procalcitonin. , 2015, Methods in molecular biology.

[73]  A. Rodríguez-Rodríguez,et al.  The utility of C-reactive protein and procalcitonin for sepsis diagnosis in critically burned patients: A preliminary study. , 2015, Plastic surgery.

[74]  Makoto Minoshima,et al.  Clinical value of procalcitonin for patients with suspected bloodstream infection. , 2014, American journal of clinical pathology.

[75]  P. Schuetz,et al.  Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients , 2013, Critical care.

[76]  F. Tubach,et al.  Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. , 2013, Evidence-based child health : a Cochrane review journal.